ライフサイエンスコーパス: on exercise

1 requency of angina and ST segment depression on exercise.

2 th underwent S-ICD ECG screening at rest and on exercise.

3 itive affect and a purpose-designed question on exercise.

4 in the standing position, and 5 (10%) failed on exercise.

5 diastolic function that become more apparent on exercise.

6 in patients, and all failed to rise normally on exercise.

7 More than 40% had hypoxemia at rest (13%) or on exercise (29%), with pulmonary hypertension (mean pul

8 d in 91% of patients; this was not different on exercise (89%) or dobutamine echocardiography (94%).

9 ltiazem (Adizem XL)/isosorbide 5-mononitrate on exercise and ambulatory myocardial ischemia during re

10 The Committee on Exercise and Cardiac Rehabilitation of the American H

11 ie the beneficial effects of this metabolite on exercise and cardiometabolic health.

12 to treat or prevent weight gain concentrate on exercise and food intake.

13 strate that muscle degeneration is dependent on exercise and force production.

14 It has beneficial effects on exercise and hemodynamics, which depend somewhat on t

15 mal maintenance of brain health might depend on exercise and intake of natural products.

16 ment of ITBFS the authors review one article on exercise and one on surgery.

17 The influence of high altitude on exercise and oxidative stress is among the recent top

18 reduced left ventricular suction at rest and on exercise, and higher end-diastolic pressures.

19 erstanding the chronic impacts of hypoxaemia on exercise, and the interactions between the alpha1 -ad

20 Finally, we discuss recent studies focusing on exercise as an important component in the management

21 Studies on exercise before and after toxin-induced hemiparkinson

22 The effects of lower doses of enoximone on exercise capacity and adverse events have not been ev

23 est the effects of treatment with ivabradine on exercise capacity and left ventricular filling in pat

24 f autonomic dysfunction and its implications on exercise capacity and mortality in long-term survivor

25 The effects of revascularization on exercise capacity and quality of life (QOL) are not w

26 the effects of tadalafil--a PDE5 inhibitor--on exercise capacity and quality of life in patients wit

27 nt trial investigated the effect of bosentan on exercise capacity in a larger number of patients and

28 2) the effect of increasing and lowering HR on exercise capacity in CHF as assessed by symptom-limit

29 s study sought to clarify the role of the HR on exercise capacity in CHF.

30 atest positive effect of any current therapy on exercise capacity in COPD; as such, gains in this are

31 (RCTs) reporting the effects of testosterone on exercise capacity in patients with HF.

32 the Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypert

33 (HFpEF), but its clinical profile and impact on exercise capacity remain unclear.

34 nces of demographic and cardiac risk factors on exercise capacity.

35 ates the beneficial effect of spironolactone on exercise capacity.

36 o evaluate the effects of low-dose enoximone on exercise capacity.

37 -response effect of potassium nitrate (KNO3) on exercise capacity; (2) the population-specific pharma

38 icular rotation, and early diastolic untwist on exercise correlated with peak VO(2)max.

39 This recommendation is based on exercise data in adults.

40 After 3 months of pacing-on, exercise duration rose from 324+/-133 to 588+/-238 s

41 On exercise dyspnea patients had lower early diastolic (

42 Tc maximum on serial ECGs (Ser QTc-max), and on exercise ECGs (Ex QTc-max) and by T-wave patterns.

43 We sought to identify extensive ischemia on exercise echocardiography (ExE) relative to workload

44 rcise electrocardiography, but its influence on exercise echocardiography has not been reported.

45 after treadmill exercise; an abnormal result on exercise electrocardiography was defined by ST segmen

46 supports the need for interventions focused on exercise, especially resistance training in the lower

47 Information on exercise habits was obtained at baseline using a vali

48 se hemodynamics and the effect of sildenafil on exercise hemodynamics in Fontan patients.

49 ures after sildenafil with no adverse effect on exercise hemodynamics suggests that it may be useful

50 hibition of NO or PGs would have less impact on exercise hyperaemia due to less vasodilatation from t

51 that ADO transporter blockade had no effect on exercise hyperaemia in either subgroup.

52 The first practice parameter on exercise-induced bronchoconstriction (EIB) was publis

53 However, the effect of PDE5 inhibition on exercise-induced ischemia in CAD patients has receive

54 Other promising recent research has focused on exercise-induced signalling pathways governing glucos

55 that the balance between the two may depend on exercise intensity and duration, the presence of prec

56 ugmented hypoxic vasodilatation is dependent on exercise intensity.

57 whether the degree of blunting is dependent on exercise intensity.

58 This Review provides an up-to-date consensus on exercise management for individuals with type 1 diabe

59 Current evidence on exercise-mediated AMPK regulation in skeletal muscle

60 s designed to assess the effect of carnitine on exercise metabolism or performance in healthy humans

61 We examined the effects of C(aO(2)) on exercise performance and its interaction with periphe

62 exercise capacity that is predictable based on exercise performance at SL.

63 The impact of this strategy on exercise performance has not been evaluated.

64 estigated the effect of erythropoietin (EPO) on exercise performance in anemic patients with CHF.

65 efinitively clarify any effects of carnitine on exercise performance in healthy persons.

66 alteration of glycogen stores and metabolism on exercise performance in patients with heart failure.

67 exerted a statistically significant benefit on exercise performance or frequency of ischemia during

68 The short-term impact of LVRS on exercise performance was evaluated using maximal and

69 On exercise performance, DKO mice show an exaggeration o

70 of rinsing with a 6.4% maltodextrin solution on exercise performance, showing it to significantly red

71 ency abrogated the positive effects of IL-37 on exercise performance.

72 structive pulmonary disease, but its effects on exercise physiology have not been investigated.

73 termine the effects of pulmonary flow splits on exercise PL.

74 able to almost complete depletion, depending on exercise protocol and muscle studied by localized MRS

75 hemia (> or =10% of the left ventricle [LV]) on exercise single-photon emission computed tomography (

76 of increased right ventricular (RV) activity on exercise single-photon emission computed tomography (

77 function and pulmonary regurgitant fraction, on exercise stress test the 22q11.2DS had significantly

78 On exercise stress test, maximum oxygen consumption was

79 ailure Questionnaire) and cardiac limitation on exercise testing (reduced peak oxygen consumption, 24

80 The ACC/AHA guidelines on exercise testing after CR (no value for routine testi

81 oxygen consumption (peak VO2) <50% predicted on exercise testing is a class I indication for heart tr

82 d significantly shorter time to angina onset on exercise testing than patients with HPT > or =41 degr

83 ians rely on exertional symptoms rather than on exercise testing to assess functional capacity in hea

84 sone use, lung function, maximal O(2) uptake on exercise testing, 6-min walk distance, and hemodynami

85 n monoxide, PaO(2) at rest, maximum workload on exercise testing, and a higher arterial-alveolar grad

86 o had one abnormal coronary artery territory on exercise thallium testing and had undergone coronary

87 ritory (either a reversible or fixed defect) on exercise thallium testing and to test the prognostic

88 e capacity and a higher prevalence of angina on exercise than patients with a normal LHR.

89 strates the importance of continued emphasis on exercise therapy, the need for a standardized approac

90 the causes of screening failure at rest and on exercise to inform optimal S-ICD ECG vector developme

91 Healthy weight control with an emphasis on exercise to preserve or increase lean muscle mass and

92 We determined the effect on exercise tolerance and physiological exercise respons

93 study of two weeks of losartan (50 mg q.d.) on exercise tolerance and quality of life.

94 The impact of these constraints on exercise tolerance cannot be determined from this inv

95 (The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients [TREPPE]; NC

96 We assessed the effect of losmapimod on exercise tolerance in patients with COPD.

97 different rate or rhythm control strategies on exercise tolerance in patients with HFpEF and AF is w

98 ngth and nine studies examining their effect on exercise tolerance.

99 similar exercise strategy (specialized hands-on exercise training, all of which included at least som

100 but the effects of non-specific antioxidants on exercise training-induced vascular adaptations remain

101 However, the effects of antioxidants on exercise training-induced vascular adaptations remain

102 measured variables included time to ischemia on exercise treadmill testing, ischemia on 48-h ambulato

103 isorder was associated with ischemic changes on exercise treadmill tests independent of traditional c

104 ; 95%CI: 1.5-48.3; p = 0.001) and E/E' ratio on exercise (unadjusted OR = 1.8, 95%CI: 0.8-4.0; p = 0.

105 art rate </=4 beats per minute) superimposed on exercise up-regulation (stroke frequency >25 strokes

106 A multiple-level classificatory system based on exercise VE/VCO2 slope stratifies the burden of risk